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ABSTRACT
Adult neurogenesis is emerging as an important player in brain functions and 
homeostasis, while impaired or altered adult neurogenesis has been associated 
with a number of neuropsychiatric diseases, such as depression and epilepsy. Here 
we investigated the possibility that synapsins (Syns) I and II, beyond their known 
functions in developing and mature neurons, also play a role in adult neurogenesis. 
We performed a systematic evaluation of the distinct stages of neurogenesis in the 
hippocampal dentate gyrus of Syn I and Syn II knockout (KO) mice, before (2-months-
old) and after (6-months-old) the appearance of the epileptic phenotype. We found 
that Syns I and II play an important role in the regulation of adult neurogenesis. 
In juvenile mice, Syn II deletion was associated with a specific decrease in the 
proliferation of neuronal progenitors, whereas Syn I deletion impaired the survival 
of newborn neurons. These defects were reverted after the appearance of the epileptic 
phenotype, with Syn I KO and Syn II KO mice exhibiting significant increases in 
survival and proliferation, respectively. Interestingly, long-term potentiation 
dependent on newborn neurons was present in both juvenile Syn mutants while, at 
later ages, it was only preserved in Syn II KO mice that also displayed an increased 
expression of brain-derived neurotrophic factor. This study suggests that Syns I and 
II play a role in adult neurogenesis and the defects in neurogenesis associated with 
Syn deletion may contribute to the alterations of cognitive functions observed in 
Syn-deficient mice.
INTRODUCTION
Adult neurogenesis is a structural form of neural 
plasticity that contributes to the maintenance of normal 
brain function and homeostasis [1]. Specifically, within 
the hippocampal dentate gyrus (DG), newborn dentate 
granule cells are known to integrate into the pre-existing 
circuitry and play a substantial role in certain types of 
learning and memory and in the modulation of emotional 
behavior or anxiety [2, 3]. Almost every stage of this 
process, from proliferation to differentiation, survival and 
integration of new neurons, can be critically modulated 
by a number of environmental and physiological factors, 
including diet, exercise and aging, or pathological 
conditions like epilepsy or neurodegenerative disorders 
[4–8]. At the molecular level, each step involves complex 
interactions among cytokines, neurotrophins and 
presynaptic proteins [9].
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Among presynaptic proteins the Synapsins (Syns), 
an abundant family of neuron-specific synaptic vesicle 
(SV)-associated phosphoproteins, play important roles 
in both neuronal development and synaptic physiology 
[10, 11]. Syns represent a convergence point for distinct 
signal transduction pathways, since they are substrates 
for cAMP-dependent, Ca2+/calmodulin-dependent I and 
II, mitogen-activated protein kinases, cyclin-dependent 
kinase-5 and pp60c-src. In mammals Syns are encoded by 
three distinct genes (SynI, SynII and SynIII) that generate 
more than ten isoforms by differential splicing. These 
transcripts are composed of a mosaic of individual and 
shared domains that are highly conserved during evolution, 
and their expression is developmentally regulated (see [11] 
for review).
Nonsense and missense mutations in SYN1/SYN2 
genes have been identified as causative for epilepsy and 
autism spectrum disorder (ASD) in humans [12–16]. In 
addition, multicenter gene mapping analysis identified 
SYN2 as one of the main genes contributing to epilepsy 
predisposition [17]. Interestingly, genetically altered 
mice lacking Syn I, Syn II or both are all prone to partial, 
secondarily generalized epileptic seizures, which appear 
at 2-3 months of age, and progressively aggravate with 
age [18–21] and exhibit cognitive disturbances compatible 
with ASD [22–24]. The epileptic propensity of Syn 
knockout (KO) mice is associated with dysfunctions in 
the excitatory/inhibitory balance in the hippocampus, 
observed well before the emergence of the overt epileptic 
phenotype and consisting in a primary impairment of 
synchronous and asynchronous GABA release [25–30].
Syn III is the most precociously expressed Syn 
isoform, consistent with a role in neuronal development 
[31]. Indeed, Syn III is expressed in nestin-positive neural 
progenitors and its constitutive depletion affects adult 
neurogenesis in the DG of the hippocampus by decreasing 
cell proliferation and enhancing survival of neural 
progenitors [32]. Moreover, in vivo downregulation of Syn 
III expression caused defects in migration and orientation 
of layer II/III neocortical pyramidal neurons [33, 34].
As Syns I and II have been shown to participate in 
neuronal development in vitro (see [10] for review), we 
addressed the possibility that these isoforms, which are 
predominantly expressed by mature neurons [31, 35], 
are also involved in the regulation of adult neurogenesis. 
Thus, we performed a systematic evaluation of the 
distinct stages of neurogenesis in the hippocampal DG of 
wild type (WT), Syn I KO and Syn II KO mice, before 
(2-months-old) and after (6-months-old) the appearance 
of the epileptic phenotype.
We found that Syns I and II, notwithstanding their 
later expression profile with respect to Syn III, also play 
important roles in the regulation of adult neurogenesis. 
Before the appearance of epilepsy, Syn II deletion is 
associated with a specific decrease of the proliferation 
of neuronal progenitors, whereas Syn I deletion impairs 
the survival of the newborn neurons. By contrast, after 
the appearance of the overt epileptic phenotype, these 
defects are reverted and survival and proliferation result 
significantly increased in Syn I KO and Syn II KO mice, 
respectively. Similar to WT mice, juvenile Syn I KO and 
Syn II KO mice expressed newborn neuron-dependent 
long-term potentiation (LTP), while this form of LTP 
was preserved at later ages only in Syn II KO mice that 
also displayed an increased expression of brain-derived 
neurotrophic factor (BDNF). The data indicate that Syns I 
and II play a role in adult neurogenesis.
RESULTS
Synapsins I and II regulate proliferation and 
survival of neural progenitor cells in the adult 
dentate gyrus
In order to examine the proliferation of neural 
progenitor cells (NPCs) in the hippocampal DG of 
2-months-old Syn I KO and Syn II KO mice, animals 
ZHUHWUHDWHGGDLO\ZLWKEURPRƍGHR[\XULGLQH%UG8
injections for six consecutive days. One day after the last 
pulse, mice were perfused (Figure 1A) and hippocampal 
VHFWLRQVSURFHVVHGIRU%UG8VWDLQLQJ&RPSDUHGZLWK:7
DQG6\Q,.2PLFHWKHQXPEHURI%UG8SRVLWLYHFHOOV
was significantly decreased in Syn II KO, indicating a 
marked reduction in hippocampal progenitor proliferation 
(Figure 1B, 1C). Similarly, the quantification of the total 
number of cells positive for doublecortin (DCX), a marker 
of neuroblasts and newly generated neurons, revealed a 
significant decrease in Syn II KO mice, suggesting that the 
impairment in proliferation produces a parallel decrease 
in the number of newborn neurons (Figure 1B, 1D). 
However, the reduction in adult hippocampal neurogenesis 
was not associated with any change in global DG or hilus 
volumes that were similar across genotypes (Figure 1E).
The survival of the progeny of dividing progenitor 
FHOOV ZDV GHWHUPLQHG WKURXJK %UG8 SXOVHFKDVH
H[SHULPHQWVE\FRXQWLQJ WKHQXPEHURI%UG8SRVLWLYH
FHOOV DQG %UG81HX1 GRXEOHSRVLWLYH FHOOV IRXQG 
GD\VDIWHUWKHODVW%UG8DGPLQLVWUDWLRQ)LJXUH$7KH
survival rate (i.e.WKHSHUFHQWDJHRI%UG8SRVLWLYHFHOOV
FRXQWHGDIWHUGD\VRYHU%UG8SRVLWLYHFHOOVIRXQGRQH
day after the last injection) in WT mice was comparable 
to those observed in previous studies (see, e.g., [32]). 
Interestingly, a significant reduction of the number of 
%UG8SRVLWLYH FHOOV DW  GD\V ZDV REVHUYHG LQ ERWK
Syn I KO and Syn II KO mice with respect to WT mice 
(Figure 2B–2D). However, when the reduced proliferation 
found in Syn II KO mice was considered (Figure 1C), the 
survival rate resulted indistinguishable from that observed 
in WT animals (Figure 2E). By contrast, the percentage 
of survival of progenitor cells was significantly impaired 
in Syn I KO mice that were characterized by a normal 
proliferative activity (Figure 2E).
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Differentiation of the surviving progenitors into 
QHXURQVRUJOLDZDVDOVRH[DPLQHGE\FRODEHOLQJRI%UG8
positive cells with the mature neurons marker NeuN and 
the astrocyte marker glial fibrillary acidic protein (GFAP). 
The percentage of differentiated neuronal and glial cells 
or undifferentiated cells, calculated on the total amount of 
%UG8SRVLWLYHFHOOVZDVVLPLODUDFURVVJHQRW\SHV)LJXUH
2F), suggesting that the absence of either Syn I or Syn II 
did not alter the fate determination of dentate progenitors.
The defects in adult neurogenesis of Synapsin I 
and Synapsin II KO mice are reverted during 
the symptomatic state of epilepsy
We next evaluated proliferation, survival and 
differentiation rates in 6-months-old animals, when both 
Syn I KO and Syn II KO mice had developed an overt 
HSLOHSWLFSKHQRW\SHE\DSSO\LQJWKHVDPH%UG8ODEHOLQJ
paradigm used above and comparing the phenotype with 
Figure 1: Neuronal progenitor proliferation in the DG of juvenile Syn I KO and Syn II KO mice. (A) Experimental 
SDUDGLJPIRU%UG8LQMHFWLRQVWRODEHOSUROLIHUDWLQJFHOOV(B) Representative images of hippocampal sections from 2-months-old WT, Syn I 
.2DQG6\Q,,.2PDOHPLFHVWDLQHGIRU%UG8JUHHQ'&;UHGDQG1HX1EOXH6FDOHEDUȝP(C, D)1XPEHURI%UG8SRVLWLYH
(C) and DCX-positive (D) cells in the subgranular zone of DG of WT (n=6), Syn I KO (n=4) and Syn II KO (n=6) mice. (E) Quantification 
of DG and hilus volumes (in mm3) in the three genotypes (n=5 for each genotype). Data are presented as means ± sem. *p<0.05, ***p< 0.001, 
one-way ANOVA/Bonferroni’s tests.
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Figure 2: Survival and differentiation of neuronal progenitors in the DG of juvenile Syn I KO and Syn II KO mice. (A) 
([SHULPHQWDOSDUDGLJPIRU%UG8LQMHFWLRQVWRODEHOVXUYLYLQJFHOOV(B) Representative images of hippocampal sections from 2-months-old 
:76\Q,.2DQG6\Q,,.2PDOHPLFHVWDLQHGIRU%UG8JUHHQ1HX1UHGDQG*)$3ZKLWH6FDOHEDUȝP(C, D) Number of 
%UG8SRVLWLYH&DQG%UGX1HX1GRXEOHSRVLWLYH'FHOOVLQWKHVXEJUDQXODU]RQHRI'*RI:7Q 6\Q,.2Q DQG6\Q,,.2
(n=7) mice. (E)6XUYLYDOUDWHVFDOFXODWHGDVSHUFHQWDJHVRI%UG8SRVLWLYHFHOOVDWGD\VZLWKUHVSHFWWRWKRVHSRVLWLYHDWGD\DIWHUWKH
ODVW%UG8LQMHFWLRQ(F)3HUFHQWDJHVRI%UG8SRVLWLYHFHOOVWKDWKDGGLIIHUHQWLDWHGLQWRQHXURQV%UG81HX1GRXEOHSRVLWLYHRUJOLD%UG8
*)$3GRXEOHSRVLWLYHRUUHPDLQHGXQGLIIHUHQWLDWHG%UG8%UG8RQO\'DWDDUHSUHVHQWHGDVPHDQVVHP*p<0.05, **p<0.01, ***p< 0.001, 
One-way ANOVA/Bonferroni’s tests.
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that of age-matched WT littermates (Figure 3A; Figure 
4A). Strikingly, the defects observed in young, non-
epileptic Syn KO mice were reverted in epileptic mice 
of the same genotype. In fact, Syn II mice showed a 
significant increase in the proliferative activity of NPCs 
%UG8SRVLWLYH FHOOV WKDW ZDV SDUDOOHOHG E\ D KLJKHU
abundance of newborn neurons (DCX-positive cells) with 
respect to either WT or Syn I KO mice (Figure 3B–3D). 
Also at this age, the volumes of the DG or the hilus in 
mutant mice were not significantly different from those of 
WT controls (Figure 3E).
By contrast, Syn I KO, but not Syn II KO, mice 
showed a significant increase in both total number of 
%UG8ODEHOOHG FHOOV DQG WRWDO DPRXQW RI %UG81HX1
Figure 3: Neuronal progenitor proliferation in the DG of symptomatic Syn I KO and Syn II KO mice. (A) Experimental 
SDUDGLJPIRU%UG8LQMHFWLRQVWRODEHOSUROLIHUDWLQJFHOOV(B) Representative images of hippocampal sections from 6-months-old WT, Syn I 
.2DQG6\Q,,.2PDOHPLFHVWDLQHGIRU%UG8JUHHQ'&;UHGDQG1HX1EOXH6FDOHEDUȝP(C, D)1XPEHURI%UG8SRVLWLYH
(C) and DCX-positive (D) cells in the subgranular zone of DG of WT, Syn I KO and Syn II KO mice (n=5 per genotype). (E) Quantification 
of DG and hilus volumes (in mm3) in the three genotypes (n=5 for each genotype). Data are presented as means ± sem. *p<0.05, **p<0.01, 
one-way ANOVA/Bonferroni’s tests.
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Figure 4: Survival and differentiation of neuronal progenitors in the DG of symptomatic Syn I KO and Syn II KO 
mice. (A)([SHULPHQWDOSDUDGLJPIRU%UG8LQMHFWLRQVWRODEHOVXUYLYLQJFHOOV(B) Representative images of hippocampal sections from 
PRQWKVROG:76\Q,.2DQG6\Q,,.2PDOHPLFHVWDLQHGIRU%UG8JUHHQ1HX1UHGDQG*)$3ZKLWH6FDOHEDUȝP(C, D) 
1XPEHURI%UG8SRVLWLYH&DQG%UGX1HX1GRXEOHSRVLWLYH'FHOOVLQWKHVXEJUDQXODU]RQHRI'*RI:7Q 6\Q,.2Q DQG
Syn II KO (n=4) mice. (E)6XUYLYDOUDWHVFDOFXODWHGDVSHUFHQWDJHVRI%UG8SRVLWLYHFHOOVDWGD\VZLWKUHVSHFWWRWKRVHSRVLWLYHDWGD\
DIWHUWKHODVW%UG8LQMHFWLRQ(F)3HUFHQWDJHVRI%UG8SRVLWLYHFHOOVWKDWKDGGLIIHUHQWLDWHGLQWRQHXURQV%UG81HX1GRXEOHSRVLWLYHRU
JOLD%UG8*)$3GRXEOHSRVLWLYHRUUHPDLQHGXQGLIIHUHQWLDWHG%UG8%UG8RQO\'DWDDUHSUHVHQWHGDVPHDQVVHP*p<0.05, **p<0.01, 
***p< 0.001, one-way ANOVA/Bonferroni’s tests.
Oncotarget18766www.oncotarget.com
GRXEOHSRVLWLYHFHOOVIRXQGGD\VDIWHU WKHODVW%UG8
injection, when compared to WT mice (Figure 4B–4D). 
$FFRUGLQJO\WKHVXUYLYDOUDWHRI%UG8ODEHOOHGFHOOVZDV
significantly increased in Syn I KO compared to either WT 
or Syn II KO mice (Figure 4E). Notably, the percentage of 
%UG81HX1GRXEOHSRVLWLYHFHOOVZDVDOVRVLJQLILFDQWO\
augmented in Syn I KO animals indicating an increase 
in neuronal differentiation of newly generated cells that 
was accompanied by a parallel significant decrease in 
the percentage of differentiated glial cells (Figure 4F). 
The percentage of undifferentiated cells was similar in all 
genotypes (Figure 4F).
Synapsin I and Synapsin II KO mice exhibit 
dysregulated BDNF signaling
Neurotrophins and neurotrophin receptors have 
been implicated in the regulation of adult neurogenesis. 
BDNF signaling is a major candidate that can elicit 
distinct physiological effects via TrkB receptors that 
bind mature BDNF (mBDNF) and support neuronal 
growth, differentiation and survival, and p75NTR that 
are activated by proBDNF, resulting in pro-apoptotic 
signaling [36]. Moreover, it is known that BDNF is 
one on the main activity-dependent determinants of 
the epileptogenic process [37] and that Syns are key 
effectors of BDNF signaling in neurons [38–40]. Thus, 
one possible mechanism by which Syn I and Syn II 
regulate adult neurogenesis is through an interplay with 
BDNF signaling. Thus, we analyzed the expression of a 
panel of regulatory molecules along the BDNF pathway 
in 2-months- and 6-months-old WT, Syn I KO and Syn II 
KO mice. Western blotting of DG extracts of 2-months-
old mice revealed a significant increase of p75NTR levels 
in both Syn I KO and Syn II KO with respect to WT mice 
(Figure 5A, 5B) and a decrease of proBDNF levels in 
Syn II KO mice (Figure 5A, 5C). On the other hand, 
at 6 months of age, a significant increase in mBDNF 
expression was only observed in Syn II KO DG in the 
absence of significant changes of BDNF receptors or 
proBDNF levels (Figure 5D–5F). These results suggest 
that the neurogenesis phenotype of Syn I KO and Syn 
II KO mice can be, at least in part, attributable to the 
dysregulation of neurotrophin signaling associated with 
the mutant genotype [40].
As neurotrophins are involved in the apoptotic 
pathways [36], we assessed whether the observed 
dysregulation of the BDNF signaling had an impact on 
cell death in Syn KO mice. Thus, we investigated active 
caspase 3-positive cells in 2- and 6-months-old WT and 
Syn KO animals. While the number of active caspase 
3-positive cells was unaffected in Syn I KO mice at both 
ages with respect to the WT controls, Syn II KO mice 
showed a significant reduction of active caspase 3-positive 
cells at 2-months of age that became less pronounced at 6 
months (Figure 6).
Long-term potentiation in the DG of pre-
symptomatic and symptomatic Syn I KO 
and Syn II KO mice
Next, we examined whether the changes in 
neurogenesis observed in Syn I KO and Syn II KO mice 
at pre-symptomatic and symptomatic temporal windows 
were associated with impaired DG synaptic plasticity. It 
has been demonstrated that, few weeks after becoming 
post-mitotic, DG newborn neurons exhibit increased 
excitability, enhanced synaptic plasticity and insensitivity 
to GABA inhibition. This condition causes a lower 
threshold for the induction of LTP that can be induced 
in the DG in the absence of GABAA receptor blockade, 
which is necessary for inducing LTP at mature DG granule 
neurons [41–44]. Thus, extracellular recordings of field 
excitatory postsynaptic potentials (fEPSPs) in response to 
high-frequency stimulation (HFS) of the medial perforant 
path (MPP) were used to estimate the magnitude of 
newborn neuron-dependent LTP in the hippocampal DG 
in the absence of GABAergic inhibitors (Figure 7A).
When LTP was assessed in 2-months-old mice, no 
significant genotype-specific changes were observed. 
WT, Syn I KO and Syn II KO mice expressed a similar 
sustained potentiation of excitatory transmission of 
about 130% of the baseline (Figure 7B–7D). However, 
when newborn neuron-dependent LTP was assessed in 
6-months-old symptomatic Syn I KO and Syn II KO mice 
and age-matched WT mice, LTP was practically absent 
in WT and Syn I KO animals, while it was preserved to 
approximately the same amplitude of the pre-symptomatic 
stage in Syn II KO mice (Figure 7E–7G).
DISCUSSION
It is now widely accepted that the generation of 
new neurons is sustained throughout life thanks to the 
proliferation and differentiation of adult NPCs in specific 
regions of the mammalian brain. This process, referred as 
adult neurogenesis, is emerging as an important player in 
brain functions and homeostasis, while impaired or altered 
adult neurogenesis has been associated with a number 
of neuropsychiatric diseases, such as depression and 
epilepsy (reviewed by [45]). However, our understanding 
of the cellular and molecular mechanisms that regulate the 
neurogenic process in the adult brain, and how this may 
contribute to neurological alterations is still limited.
Here, we report that genetic deletion of either 
Syn I or Syn II alters distinct stages of neurogenesis in 
the hippocampal DG of juvenile mice. In particular, we 
observed a specific role for Syn II in the proliferation 
of neural progenitor cells, while Syn I appears to be 
mainly involved in the survival of the newborn neurons. 
As a result, the total number of newborn neurons was 
lower in both Syn I KO and Syn II KO mice, due to 
either decreased survival or proliferation rates, while the 
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Figure 5: BDNF signaling in the DG of juvenile and symptomatic Syn I KO and Syn II KO mice. (A, D) Representative 
immunoblots of the expression of p75NTR, full length TrkB receptor (TrkB.tk+), truncated TrkB (TrkB.t1), phosphorylated TrkB (pTrkB), 
proBDNF and mature BDNF (mBDNF) in the DG of 2-months-old (A) and 6-months-old (D) WT, Syn I KO and Syn II KO mice. Gapdh 
was used as control of equal loading. (B, E) Quantification of the expression levels of BDNF receptors and TrkB phosphorylation. (C, F) 
Quantification of the expression levels of proBDNF and mBDNF. Data (means ± sem) were normalized to Gapdh and expressed as 
percentages of the respective levels in WT mice (n = 4 for each genotype). * p<0.05, ***p<0.001, one-way ANOVA/Dunett’s test.
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commitment of NPCs towards the neuronal phenotype 
was preserved. Since juvenile mice have not developed 
the epileptic syndrome yet, the observed effects can be 
directly related to the lack of expression of Syn I or Syn II 
or to secondary effects of their gene deletion.
Syns have been extensively described as essential 
modulators of proper neuronal development and function, 
such as establishment of neuronal polarity, neurite 
elongation and synapse formation, with non-redundant 
functions of the various isoforms [10, 11]. Syn III, the 
most precociously expressed Syn isoform, has been 
associated with profound alterations in adult neurogenesis, 
with decreased proliferation of NPCs and a compensatory 
increase in their survival and neuronal differentiation, 
resulting in no change in the number of newborn neurons 
and in the DG volume [32]. The alterations of adult 
neurogenesis in Syn I KO and Syn II KO mice testifies 
that, although the expression of both Syn I and Syn II 
is boosted in developing neurons and peaks at the time 
of synapse formation, the proteins play a role also in 
the more precocious stages of neurogenesis. Indeed, a 
previous report described a decrease in the number of 
Ki67- and DCX-positive cells in 2-months-old Syn II KO 
[46] consistently with our data in the pre-symptomatic 
stage of these mice.
The distinct neurogenic phenotype of Syn I KO 
and Syn II KO mice in the proliferation and survival of 
NPCs correlates with the distinct developmental roles and 
biochemical properties of the two Syn isoforms [10, 11]. 
In spite of the different mechanism, however, the number 
of surviving NPCs is decreased by approximately the same 
extent in the absence of either isoform.
It is also possible that the perturbation of the 
neurogenesis, characterizing Syn I KO and Syn II KO 
mice, is attributable, at least in part, to secondary effects 
of gene deletion. We recently demonstrated that primary 
cortical neurons of both Syn I KO and Syn I/II/III KO 
display increased levels of p75NTR [40], a result that we 
confirmed here in vivo for both mutant genotypes at 2 
months of age. Thus, the decreased neuronal survival rate 
Figure 6: Apoptotic cell death rates in the DG of Syn I KO and Syn II KO mice. (A) Immunofluorescence images of active 
caspase 3-labeled cells (green) in DG sections of 2- and 6-months-old WT, Syn I KO and Syn II KO mice. Sections were counterstained 
ZLWK+RHFKVWEOXH6FDOHEDUȝP(B, C) Number of active caspase 3-positive cells in the subgranular zone of DG of 2-months-old WT 
(n=6), Syn I KO (n=4) and Syn II KO (n=7) mice (B) and 6-months-old WT (n=6), Syn I KO (n=6) and Syn II KO (n=5) mice (C). Data 
are presented as means ± sem. **p<0.01, one-way ANOVA/Bonferroni’s test.
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Figure 7: Neurogenesis-dependent LTP in the DG of juvenile and symptomatic Syn I KO and Syn II KO mice. (A) 
Experimental configuration. Left: position of the stimulating and recording electrodes in the MPP and molecular layer, respectively. Right: 
the stimulation of the MPP fibers induces a PP depression. (B, E) Representative fEPSPs evoked in 2-months-old (B) and 6-months-old (E) 
WT, Syn I KO and Syn II KO hippocampal slices before (black traces) and after (colored traces) the induction of the LTP. (C, F) Plot of the 
fEPSP slope before and after the induction of the LTP (time 0) in the DG of 2-months-old (C) and 6-months-old (F) WT (blue traces), Syn 
I KO (red traces) and Syn II KO (green traces) mice. The extent of LTP was calculated as a percentage of the baseline between the last 40 
and 60 min of recording. (D, G) Histogram of the LTP amplitude in 2-months-old (D) and 6-months-old (G) WT, Syn I KO and Syn II KO 
mice. Data are presented as mean ± sem. 2-months-old mice: n=8 slices from 4 WT; n=7 slices from 3 Syn I KO; n=7 from 3 Syn II KO. 
6-months-old mice: n=10 slices from 4 WT; n=12 slices from 4 Syn I KO; n=12 from 4 Syn II KO. **p<0.01, ***p<0.001, one-way ANOVA/
Bonferroni’s test.
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of Syn I KO may be due to the increased p75NTR signaling. 
By contrast, the concomitant decrease of the p75NTR ligand 
proBDNF in Syn II KO mice could dampen the effects 
of increased p75NTR signaling, resulting in unaltered or 
even increased survival rate of neural progenitors. Indeed, 
the number of apoptotic cells was significantly reduced 
in 2-months-old Syn II KO mice. However, the reduced 
number of apoptotic cells in 2-months-old Syn II KO 
mice can also be contributed by the reduced proliferation 
rate observed in these mice. In 6-months-old mice, both 
proliferation and apoptotic rates were lower than in 
younger animals. At this age, Syn II KO mice showed the 
higher proliferation rate, but also a trend towards lower 
apoptotic elimination. This apparent discrepancy can be, at 
least in part, attributable to the concomitant sharp increase 
in mBDNF in 6-months-old Syn II KO mice that may 
downregulate the apoptotic process.
In mice lacking Syn I or Syn II, epileptic seizures 
start developing approximately at 2-3 months of age, 
progressively aggravate with age [22]. Thus, any alteration 
of neurogenesis in symptomatic Syn I KO and Syn II 
KO mice may result from both the genotype and the 
appearance of epileptic seizures. Seizure activity involving 
the hippocampus strongly affects adult neurogenesis in 
the DG, although it is not clear whether seizure-induced 
aberrant neurogenesis is part of the epileptogenic process 
and contributes to the disease or represents an attempt 
to repair the injured brain structures and compensate 
for the neuronal loss due to seizures [47–49]. Further 
studies will be needed to understand weather changes in 
neurogenesis are a consequence of epilepsy in Syns KO 
mice or if instead changes in neurogenesis play a role in 
the establishing the epileptic phenotype in these mice. 
Nevertheless, in epileptic Syn I KO and Syn II KO mice, 
the neurogenic defects observed in the pre-symptomatic 
phase were compensated, with a resulting increase in NPC 
proliferation in Syn II KO and of NPC survival in Syn I 
KO mice. The effect on NPC proliferation and the increase 
in mBDNF expression were particularly intense in Syn II 
KO mice, in parallel with the higher severity of seizure 
activity in these mice. BDNF is one of the main actors 
of epileptogenesis and of epilepsy-induced neurogenesis. 
Indeed, it has been shown that intra-hippocampal infusion 
of BDNF in adult rats increases DG neurogenesis, while 
heterozygous BDNF KO mice display impaired NPC 
proliferation [50, 51].
It is known that manipulations that inhibit adult 
neurogenesis prevent the induction of LTP evoked by MPP 
stimulation in the DG of slices with intact GABAergic 
transmission [41, 43]. This demonstrates that this form 
of long-term plasticity is mediated by newborn granule 
neurons that are subjected to a lower inhibitory tone than 
mature DG granule cells. In spite of the changes in NPC 
survival and proliferation observed in juvenile Syn I KO 
and Syn II KO mice, respectively, no major genotype-
dependent effects in the expression of LTP were observed. 
This indicates that, notwithstanding the alterations in NPC 
generation and survival observed in pre-symptomatic Syn 
KO mice, the final output of post-mitotic DG newborn 
neurons is sufficient to express physiological amplitudes 
of newborn neuron-dependent DG-LTP. At 6 months of 
age, no newborn neuron-dependent LTP was elicited in 
WT mice, consistent with the previously reported decrease 
of threshold and amplitude of newborn neuron-dependent 
LTP with aging [52, 53]. In spite of the similar epileptic 
phenotype, LTP was maintained in Syn II KO mice, but 
was absent in Syn I KO mice. The specific preservation 
of LTP in Syn II KO may result from several factors, 
including: (i) the observed increase in NPC proliferation 
and increased mBDNF levels in symptomatic Syn II KO 
mice and (ii) the distinct epileptogenic pathways recently 
identified in Syn I and II KO mice. Although both Syn I 
KO and II KO mice display dysfunctions in GABAergic 
transmission resulting in an excitation/inhibition 
imbalance, deletion of Syn I generates a deficit of phasic 
inhibition [26, 27], while deletion of Syn II abolishes tonic 
inhibition [29, 30]. Recent experimental evidence has 
demonstrated that increased tonic inhibition induced by 
treatment with agonists of extrasynaptic GABAA receptors 
[54] or by altered astrocyte GABA release [55] impaired 
LTP in the hippocampal DG. Thus, the lack of GABAergic 
tonic inhibition that we identified in DG granule cells of 
the Syn II KO could explain the persistence of LTP that 
characterizes the DG of symptomatic Syn II KO mice.
In conclusion, our findings implicate Syn I and Syn 
II in distinct aspects of adult DG neurogenesis, providing a 
basis for further explorations of the molecular mechanisms 
underlying the modulation of neurogenesis in the adult 
brain. Since deficiency or mutations of Syn I and Syn II 
are associated with the emergence of epilepsy and autism 
spectrum disorders in humans, our results open interesting 
questions on the role of neurogenesis in the pathogenesis 
of these diseases. Further studies are needed to clarify the 
interplay between the neurogenesis deficits and the brain 
alterations underlying the appearance of the epileptic/
autistic phenotype in these mice.
MATERIALS AND METHODS
Histological evaluation of neurogenesis
Neurogenesis quantification was performed on 2- 
and 6-months-old C57BL/6J WT, Syn I KO and Syn II KO 
male mice and WT littermates using the thymidine analog 
%UG8>@$OODQLPDOH[SHULPHQWVZHUHSHUIRUPHGLQ
accordance with the guidelines established by the European 
&RPPXQLW\&RXQFLO'LUHFWLYH(8RI6HSWHPEHU
22, 2010) and were approved by the Italian Ministry of 
Health. The animals were injected intraperitoneally with 
PJ.JERG\ZHLJKW%UG8RQFHGDLO\IRUGD\V2QH
GD\ DQG  GD\V DIWHU WKH ODVW%UG8 LQMHFWLRQ DQLPDOV
were deeply anesthetized and transcardially perfused 
with 4 % paraformaldehyde in 100 mM phosphate buffer, 
S+&RURQDOVHFWLRQVȝPZHUHFXWRQDIUHH]LQJ
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VOLGLQJPLFURWRPH7KHUPR6FLHQWLILF+0)RU%UG8
immunohistochemistry, sections were pretreated with 2 N 
HCl as previously described [8] to denature DNA, washed 
with phosphate-buffered saline (PBS) and incubated for 
1 h at room temperature in PBS containing 0.1 % Triton 
(PBST) and 5 % fetal bovine serum (blocking buffer). 
Sections were then incubated overnight at 4°C with the 
following primary antibodies in blocking buffer: rat 
DQWL%UG8$EFDPPRXVHDQWL1HX10LOOLSRUH
1:250), rabbit anti-DCX (Abcam 1:1000), rabbit anti-
GFAP (Abcam 1:200) and rabbit anti-active caspase 3 
(R&D System 1:500). After washing in PBST, secondary 
antibodies Alexa Fluor 488 goat anti-rat IgG, Alexa Fluor 
568 goat anti-rabbit IgG, Alexa Fluor 647 goat anti-mouse 
IgG (Molecular Probes) 1:1000 were incubated for 2 h 
at room temperature. Sections were counterstained with 
Hoechst 33342 (Sigma-Aldrich) to detect nuclei, mounted 
with Prolong Gold (Invitrogen), and coverslipped. Images 
were taken with a Nikon A1 confocal microscope through 
a 40x objective.
Quantification of BrdU-, BrdU/NeuN-, BrdU/
DCX- and active caspase 3-positive cells
For the assessment of adult DG neurogenesis and 
active caspase 3-positive cells, stereological cell counting 
ZDVSHUIRUPHGLQVHULDOFRURQDOVHFWLRQVȝPSLWFK
covering the complete rostro-caudal extension of the DG, 
as previously described [8]. Fluorescence images were 
captured with a Nikon A1 confocal scanning microscope 
equipped with a 40x air objective and a motorized stage. 
)RUHDFKVHFWLRQFRQIRFDO]VWDFNLPDJHVȝP]VWHS
size) covering the complete DG were acquired and DG 
reconstructed with the NIS Element AR software (Nikon). 
Immunopositive cells in the granular cell layer (GCL) and 
WKHVXEJUDQXODU]RQH6*=GHILQHGDVDȝPUHJLRQ
below the GCL) were counted on the reconstructed images 
by an operator blind to the experimental groups according, 
to the optical dissector principle [57].
Assessment of DG and hilus volume
For the quantification of DG and hilus volumes, 
slices were stained with NeuN and acquired by confocal 
microscopy. The profile area of each section was measured 
using NIS-Elements AR Microscope Imaging Software. 
The volume estimation of these brain regions was obtained 
by multiplying the sum of the areas of all sections by the 
distance between the sections applying the principle of 
Cavalieri [58].
Western blotting analysis
Mice were euthanized, brains removed and 
hippocampi dissected out, quickly frozen and stored 
DW í& )UR]HQ WLVVXHVZHUH KRPRJHQL]HG DW & LQ
ȝORI;FROG3%6FRQWDLQLQJDFRFNWDLORISURWHDVH
and phosphatase inhibitors (Halt Phosphatase Inhibitor 
Cocktail, Thermo Scientific) and sonicated two times 
for 10 s. Samples were then clarified by centrifugation 
at 1000 x g for 10 min at 4°C and the supernatant 
recovered. Protein concentrations were determined using 
the colorimetric Bradford assay (Bio-Rad Laboratories). 
(TXLYDOHQW DPRXQWV RI SURWHLQV  ȝJODQH ZHUH
subjected to sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS–PAGE) on 9 % polyacrylamide gels 
and blotted onto nitrocellulose membranes (Whatman, 
Sigma-Aldrich). After the transfer, membranes were 
blocked with 5 % non-fat dry milk or BSA in Tris-buffered 
saline (TBS) containing 0.1 % Triton X-100 (TBST) for 
1 h at room temperature and incubated either overnight 
at 4°C or for 2 h at room temperature with the following 
primary antibodies: rabbit anti-GAPDH (1:5000; Abcam), 
rabbit anti-p75NTR (1:1000; Cell Signaling), rabbit anti-
BDNF and Y706P-TrkB (1:500; Santa Cruz Biotechnology). 
After three washes, membranes were incubated for 1 h at 
room temperature with horseradish peroxidase (HRP)-
conjugated anti-rabbit (1:3000; Bio-Rad Laboratories) 
antibodies. Bands were revealed with the ECL 
chemiluminescence detection system (Thermo Scientific) 
and fluorograms were quantified by densitometric 
analysis.
Hippocampal slices and field recordings
Horizontal hippocampal slices were obtained 
from 2- and 6-months-old WT, Syn I and II KO male 
littermates. Mice were anaesthetized with isoflurane and 
decapitated; the brain was quickly removed and immersed 
in an ice-cold ‘cutting’ solution saturated with 95% O2 and 
5% CO2 and composed of (mM): 87 NaCl, 25 NaHCO3, 
2.5 KCl, 0.5 CaCl2, 7 MgCl2, 25 glucose, 75 sucrose. 
7KHGLVVHFWHGKHPLVSKHUHVZHUHFXW LQWRȝPWKLFN
slices using an HM 650 Vibratome (Microm International 
GmbH, Walldorf, Germany). Slices were incubated 
at 35°C for 1 h and then stored at room temperature in 
‘standard recording solution’ saturated with 95 % O2 and 
5 % CO2 and composed of (mM): 125 NaCl, 25 NaHCO3, 
25 glucose, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2. 
Slices were transferred into a ‘submerged’ recording 
chamber continuously superfused at a rate of 1.5 ml/min 
with the ‘standard recording solution’. Synaptic inhibitors 
were not used in order to induce a neurogenesis-dependent 
LTP as previously described [41]. The bath temperature 
was monitored and maintained at 30 ± 1°C. Extracellular 
field potentials were recorded in the molecular layer of the 
DG with glass microelectrodes (1-2 MOhm) filled with 
standard recording solution. Electrical stimulation was 
delivered through a monopolar glass electrode connected 
with an isolated pulse stimulator (A-M Systems, Carlsborg, 
WA) positioned into the MPP. We applied paired-pulse 
(PP) protocol at 200 ms to test the correct position of 
the stimulation electrode, since the MPP-DG granule 
cell synapse is characterized by PP depression [59]. The 
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stimulation intensity was determined based on the input/
output (I/O) relationship, and the stimulation intensity that 
produced 50% of the maximal response was used for test 
pulses and tetanic stimulation. The stimulus duration was 
0.1 ms. Field EPSPs were acquired by using a MultiClamp 
700B (Axon Instruments, Molecular Devices, Sunnyvale, 
&$86$DPSOLILHUDQGWKHS&ODPSVRIWZDUH$[RQ
Instruments). The fEPSP slope was evaluated as a linear 
regression of the rise phase from 20% to 80% of the 
fEPSP amplitude using Clampex 9.2 software (Axon 
Instruments). For each experiment, the ‘baseline slope’ 
was calculated by averaging the slope values obtained 
after the stimulation of the MPP fibers at 0.03 Hz for 20 
min. The magnitude of fEPSPs was measured as slope 
normalized to baseline and plotted against time. To study 
LTP, baseline responses were evoked every 30 s for 20 
min before LTP induction. LTP was evoked by 4 trains at 
100 Hz, 500 ms each, repeated every 20 s. Time-point 0 
marks the application of the first LTP-inducing stimulus. 
The post-tetanic responses were then measured every 30 
s for 60 min. LTP was estimated as percentage change 
of the baseline fEPSP slope and, for each recording, the 
final magnitude of LTP was determined as the average of 
responses between 40 and 60 min post-induction.
Statistical analysis
Data are reported as means ± sem throughout. 
Normal distribution of data was assessed using the 
D’Agostino-Pearson’s normality test. When data were 
normally distributed, one- or two-way ANOVA followed 
by either Dunnett’s or Bonferroni’s multiple comparison 
test. The significance level was preset to p<0.05. Statistical 
analysis was carried out using Prism/GraphPad (GraphPad 
Software, Inc.) software.
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